Article
The Heterogeneity Metabolism of Renal Cell Carcinomas.
Advances in experimental medicine and biology - 1 Jan 2021
Zarisfi Mohammadreza, Nguyen Tu, Nedrow Jessie R, Le Anne
Abstract excerpt
According to data from the American Cancer Society, cancer is one of the deadliest health problems globally. Annually, renal cell carcinoma (RCC) causes more than 100,000 deaths worldwide [1-4], posing an urgent need to develop effective treatments to increase patient survival outcomes. New therapies are expected to address a major factor contributing to cancer's resistance to standard therapies: oncogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
